Obviously the most exciting applications would be for macrocycles that are orally active, cell penetrant drugs that open up totally novel, untapped targets.
Like most drugs, the key will be to differentiate them from known modalities (and other macrocycles), and this will fundamentally depend on a target-by-target, disease-by-disease analysis.